{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:52:51Z","timestamp":1774867971008,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00702-011-0756-9","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T05:26:23Z","timestamp":1325568383000},"page":"645-652","source":"Crossref","is-referenced-by-count":16,"title":["Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice"],"prefix":"10.1007","volume":"119","author":[{"given":"Katarzyna","family":"Soca\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Nieoczym","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,4]]},"reference":[{"key":"756_CR1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","volume":"168","author":"RC Almeida","year":"2006","unstructured":"Almeida RC, Felisbino CS, Lopez MG, Rodrigues AL, Gabilan NH (2006) Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res 168:318\u2013322","journal-title":"Behav Brain Res"},{"key":"756_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2006.11.006","volume":"7","author":"MS Ansorge","year":"2007","unstructured":"Ansorge MS, Hen R, Gingrich JA (2007) Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol 7:8\u201317","journal-title":"Curr Opin Pharmacol"},{"key":"756_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00702-007-0806-5","volume":"115","author":"CB Brink","year":"2008","unstructured":"Brink CB, Clapton JD, Eagar BE, Harvey BH (2008) Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J Neural Transm 115:117\u2013125","journal-title":"J Neural Transm"},{"key":"756_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2008.08.033","volume":"598","author":"PS Brocardo","year":"2008","unstructured":"Brocardo PS, Budni J, Lobato KR, Kaster MP, Rodrigues AL (2008) Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur J Pharmacol 598:37\u201342","journal-title":"Eur J Pharmacol"},{"key":"756_CR5","first-page":"114","volume-title":"Goodman and Gilman\u2019s manual of pharmacology and therapeutics","author":"L Brunton","year":"2008","unstructured":"Brunton L, Parker K, Blumenthal D, Buxton I (2008) Muscarinic receptor agonists and antagonists. In: Brunton L, Parker K, Blumenthal D, Buxton I (eds) Goodman and Gilman\u2019s manual of pharmacology and therapeutics. The McGrow-Hill Companies, New York, pp 114\u2013125"},{"key":"756_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3228","volume":"14","author":"NS Bryan","year":"2009","unstructured":"Bryan NS, Bian K, Murad F (2009) Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 14:1\u201318","journal-title":"Front Biosci"},{"key":"756_CR7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1999.tb09320.x","volume":"877","author":"D Chau","year":"1999","unstructured":"Chau D, Rada PV, Kosloff RA, Hoebel BG (1999) Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine. Ann N Y Acad Sci 877:769\u2013774","journal-title":"Ann N Y Acad Sci"},{"key":"756_CR8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0306-4522(01)00133-6","volume":"104","author":"DT Chau","year":"2001","unstructured":"Chau DT, Rada P, Kosloff RA, Taylor JL, Hoebel BG (2001) Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test. Neuroscience 104:791\u2013798","journal-title":"Neuroscience"},{"key":"756_CR9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","volume":"31","author":"A Dhir","year":"2007","unstructured":"Dhir A, Kulkarni SK (2007a) Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog Neuropsychopharmacol Biol Psychiatry 31:921\u2013925","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"756_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","volume":"568","author":"A Dhir","year":"2007","unstructured":"Dhir A, Kulkarni SK (2007b) Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568:177\u2013185","journal-title":"Eur J Pharmacol"},{"key":"756_CR11","first-page":"164","volume":"46","author":"A Dhir","year":"2008","unstructured":"Dhir A, Kulkarni SK (2008) Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801 (dizocilpine), a NMDA receptor antagonist in mouse forced swim test. Indian J Exp Biol 46:164\u2013170","journal-title":"Indian J Exp Biol"},{"key":"756_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0173(86)90016-0","volume":"396","author":"SC Dilsaver","year":"1986","unstructured":"Dilsaver SC (1986) Cholinergic mechanisms in depression. Brain Res 396:285\u2013316","journal-title":"Brain Res"},{"key":"756_CR13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0006-3223(86)90294-5","volume":"21","author":"SC Dilsaver","year":"1986","unstructured":"Dilsaver SC, Snider RM, Alessi NE (1986) Stress induces supersensitivity of a cholinergic system in rats. Biol Psychiatry 21:1093\u20131096","journal-title":"Biol Psychiatry"},{"key":"756_CR14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","volume":"67","author":"WC Drevets","year":"2010","unstructured":"Drevets WC, Furey ML (2010) Replication of scopolamine\u2019s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry 67:432\u2013438","journal-title":"Biol Psychiatry"},{"key":"756_CR15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","volume":"63","author":"ML Furey","year":"2006","unstructured":"Furey ML, Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121\u20131129","journal-title":"Arch Gen Psychiatry"},{"key":"756_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","volume":"18","author":"M Ghasemi","year":"2008","unstructured":"Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR (2008) Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 18:323\u2013332","journal-title":"Eur Neuropsychopharmacol"},{"key":"756_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 5:689\u2013702","journal-title":"Nat Rev Drug Discov"},{"key":"756_CR18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.physbeh.2004.09.005","volume":"83","author":"AK Hotchkiss","year":"2005","unstructured":"Hotchkiss AK, Pyter LM, Gatien ML, Wen JC, Milman HA, Nelson RJ (2005) Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiol Behav 83:683\u2013688","journal-title":"Physiol Behav"},{"key":"756_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1410.018","volume":"1148","author":"M Jabbi","year":"2008","unstructured":"Jabbi M, Korf J, Ormel J, Kema IP, den Boer JA (2008) Investigating the molecular basis of major depressive disorder etiology: a functional convergent genetic approach. Ann N Y Acad Sci 1148:42\u201356","journal-title":"Ann N Y Acad Sci"},{"key":"756_CR20","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","volume":"2","author":"DS Janowsky","year":"1972","unstructured":"Janowsky DS, el Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic\u2013adrenergic hypothesis of mania and depression. Lancet 2:632\u2013635","journal-title":"Lancet"},{"key":"756_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","volume":"36","author":"DS Janowsky","year":"1974","unstructured":"Janowsky DS, el Yousef MK, Davis JM (1974) Acetylcholine and depression. Psychosom Med 36:248\u2013257","journal-title":"Psychosom Med"},{"key":"756_CR22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.pnpbp.2008.08.010","volume":"32","author":"CR Jesse","year":"2008","unstructured":"Jesse CR, Bortolatto CF, Savegnago L, Rocha JB, Nogueira CW (2008) Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 32:1838\u20131843","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"756_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)00830-5","volume":"415","author":"B Karolewicz","year":"2001","unstructured":"Karolewicz B, Paul IA (2001) Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol 415:197\u2013201","journal-title":"Eur J Pharmacol"},{"key":"756_CR24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","volume":"165","author":"MP Kaster","year":"2005","unstructured":"Kaster MP, Ferreira PK, Santos AR, Rodrigues AL (2005a) Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 165:204\u2013209","journal-title":"Behav Brain Res"},{"key":"756_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","volume":"8","author":"MP Kaster","year":"2005","unstructured":"Kaster MP, Rosa AO, Santos AR, Rodrigues AL (2005b) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int J Neuropsychopharmacol 8:601\u2013606","journal-title":"Int J Neuropsychopharmacol"},{"key":"756_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894\u2013902","journal-title":"Nature"},{"key":"756_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2008.05.043","volume":"589","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Dhir A (2008) On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 589:163\u2013172","journal-title":"Eur J Pharmacol"},{"key":"756_CR28","first-page":"353","volume":"56","author":"M Kurt","year":"2004","unstructured":"Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y (2004) Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol 56:353\u2013357","journal-title":"Pol J Pharmacol"},{"key":"756_CR29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FBP.0b013e32833befe5","volume":"21","author":"N Liebenberg","year":"2010","unstructured":"Liebenberg N, Harvey BH, Brand L, Brink CB (2010a) Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. Behav Pharmacol 21:540\u2013547","journal-title":"Behav Pharmacol"},{"key":"756_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2010.01.032","volume":"209","author":"N Liebenberg","year":"2010","unstructured":"Liebenberg N, Wegener G, Harvey BH, Brink CB (2010b) Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism. Behav Brain Res 209:137\u2013141","journal-title":"Behav Brain Res"},{"key":"756_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","volume":"216","author":"K Loughney","year":"1998","unstructured":"Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase. Gene 216:139\u2013147","journal-title":"Gene"},{"key":"756_CR32","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/j.1742-1241.2007.01602.x","volume":"61","author":"V Maletic","year":"2007","unstructured":"Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, Russell J (2007) Neurobiology of depression: an integrated view of key findings. Int J Clin Pract 61:2030\u20132040","journal-title":"Int J Clin Pract"},{"key":"756_CR33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","volume":"7","author":"HK Manji","year":"2001","unstructured":"Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541\u2013547","journal-title":"Nat Med"},{"key":"756_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-2999(88)90470-0","volume":"157","author":"M McKinney","year":"1988","unstructured":"McKinney M, Lee NH, Anderson DJ, Vella-Rountree L, el Fakahany EE (1988) Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays. Eur J Pharmacol 157:51\u201360","journal-title":"Eur J Pharmacol"},{"key":"756_CR35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1097-4679(199403)50:2<286::AID-JCLP2270500223>3.0.CO;2-P","volume":"50","author":"J Mearns","year":"1994","unstructured":"Mearns J, Dunn J, Lees-Haley PR (1994) Psychological effects of organophosphate pesticides: a review and call for research by psychologists. J Clin Psychol 50:286\u2013294","journal-title":"J Clin Psychol"},{"key":"756_CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0091-3057(82)90279-9","volume":"17","author":"LR Meyerson","year":"1982","unstructured":"Meyerson LR, Wennogle LP, Abel MS, Coupet J, Lippa AS, Rauh CE, Beer B (1982) Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:159\u2013163","journal-title":"Pharmacol Biochem Behav"},{"key":"756_CR37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1345\/aph.1A402","volume":"36","author":"HA Milman","year":"2002","unstructured":"Milman HA, Arnold SB (2002) Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 36:1129\u20131134","journal-title":"Ann Pharmacother"},{"key":"756_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","volume":"31","author":"YS Mineur","year":"2010","unstructured":"Mineur YS, Picciotto MR (2010) Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 31:580\u2013586","journal-title":"Trends Pharmacol Sci"},{"key":"756_CR39","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet 349:1498\u20131504","journal-title":"Lancet"},{"key":"756_CR40","first-page":"263","volume-title":"The American psychiatric publishing textbook of psychopharmacology","author":"CJ Nelson","year":"2009","unstructured":"Nelson CJ (2009) Tricyclic and tetracyclic drugs. In: Schatzberg AF, Nemeroff CB (eds) The American psychiatric publishing textbook of psychopharmacology. American Psychiatric Publishing, Arlington, pp 263\u2013288"},{"key":"756_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13\u201325","journal-title":"Neuron"},{"key":"756_CR42","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1528-1167.2009.02485.x","volume":"51","author":"D Nieoczym","year":"2010","unstructured":"Nieoczym D, \u0141uszczki JJ, Czuczwar SJ, Wla\u017a P (2010a) Effect of sildenafil on the anticonvulsant action of classical and second-generation antiepileptic drugs in maximal electroshock-induced seizures in mice. Epilepsia 51:1552\u20131559","journal-title":"Epilepsia"},{"key":"756_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1734-1140(10)70278-4","volume":"62","author":"D Nieoczym","year":"2010","unstructured":"Nieoczym D, Soca\u0142a K, Rundfeldt C, Wla\u017a P (2010b) Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in rats. Pharmacol Rep 62:383\u2013391","journal-title":"Pharmacol Rep"},{"issue":"Suppl 10","key":"756_CR44","first-page":"20","volume":"64","author":"HG Nurnberg","year":"2003","unstructured":"Nurnberg HG, Hensley PL (2003) Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. J Clin Psychiatry 64(Suppl 10):20\u201325","journal-title":"J Clin Psychiatry"},{"key":"756_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00432254","volume":"78","author":"DH Overstreet","year":"1982","unstructured":"Overstreet DH, Russell RW (1982) Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 78:150\u2013155","journal-title":"Psychopharmacology (Berl)"},{"key":"756_CR46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","volume":"29","author":"DH Overstreet","year":"2005","unstructured":"Overstreet DH, Friedman E, Mathe AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739\u2013759","journal-title":"Neurosci Biobehav Rev"},{"key":"756_CR47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","volume":"11","author":"P Pacher","year":"2004","unstructured":"Pacher P, Kecskemeti V (2004) Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 11:925\u2013943","journal-title":"Curr Med Chem"},{"key":"756_CR48","first-page":"361","volume":"42","author":"CS Patil","year":"2004","unstructured":"Patil CS, Jain NK, Singh VP, Kulkarni SK (2004) Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. Indian J Exp Biol 42:361\u2013367","journal-title":"Indian J Exp Biol"},{"key":"756_CR49","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"756_CR50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4065\/76.5.511","volume":"76","author":"E Richelson","year":"2001","unstructured":"Richelson E (2001) Pharmacology of antidepressants. Mayo Clin Proc 76:511\u2013527","journal-title":"Mayo Clin Proc"},{"key":"756_CR51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/10532528.2002.10559802","volume":"13","author":"RC Rosen","year":"2002","unstructured":"Rosen RC, McKenna KE (2002) PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annu Rev Sex Res 13:36\u201388","journal-title":"Annu Rev Sex Res"},{"key":"756_CR52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pbb.2007.09.015","volume":"88","author":"L Savegnago","year":"2008","unstructured":"Savegnago L, Jesse CR, Pinto LG, Rocha JB, Barancelli DA, Nogueira CW, Zeni G (2008) Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88:418\u2013426","journal-title":"Pharmacol Biochem Behav"},{"key":"756_CR53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archpsyc.1977.01770140126014","volume":"34","author":"SH Snyder","year":"1977","unstructured":"Snyder SH, Yamamura HI (1977) Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34:236\u2013239","journal-title":"Arch Gen Psychiatry"},{"key":"756_CR54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1192\/bjp.137.5.433","volume":"137","author":"E Szabadi","year":"1980","unstructured":"Szabadi E, Gaszner P, Bradshaw CM (1980) The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers. Br J Psychiatry 137:433\u2013439","journal-title":"Br J Psychiatry"},{"key":"756_CR55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.yic.0000117902.43995.b0","volume":"19","author":"J Tignol","year":"2004","unstructured":"Tignol J, Furlan PM, Gomez-Beneyto M, Opsomer R, Schreiber W, Sweeney M, Wohlhuter C (2004) Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol 19:191\u2013199","journal-title":"Int Clin Psychopharmacol"},{"key":"756_CR56","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.105.088849","volume":"315","author":"K Ushijima","year":"2005","unstructured":"Ushijima K, Sakaguchi H, Sato Y, To H, Koyanagi S, Higuchi S, Ohdo S (2005) Chronopharmacological study of antidepressants in forced swimming test of mice. J Pharmacol Exp Ther 315:764\u2013770","journal-title":"J Pharmacol Exp Ther"},{"key":"756_CR57","first-page":"150","volume":"59","author":"S Uthayathas","year":"2007","unstructured":"Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M (2007) Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep 59:150\u2013163","journal-title":"Pharmacol Rep"},{"key":"756_CR58","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.0953-816X.2004.03327.x","volume":"19","author":"WC Staveren van","year":"2004","unstructured":"van Staveren WC, Steinbusch HW, Markerink-van Ittersum M, Behrends S, de Vente J (2004) Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry. Eur J Neurosci 19:2155\u20132168","journal-title":"Eur J Neurosci"},{"key":"756_CR59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","volume":"20","author":"AD Zomkowski","year":"2010","unstructured":"Zomkowski AD, Engel D, Gabilan NH, Rodrigues AL (2010) Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur Neuropsychopharmacol 20:793\u2013801","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00702-011-0756-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T11:56:20Z","timestamp":1742212580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0756-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,4]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0756-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,4]]}}}